PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
ARGX argenx SE
- 639.410
- -11.930-1.83%
Close Feb 14 16:00 ET
- 639.410
- 0.0000.00%
Post 20:01 ET
38.85BMarket Cap-819.76P/E (TTM)
649.975High632.149Low266.82KVolume649.420Open651.340Pre Close170.31MTurnover0.44%Turnover RatioLossP/E (Static)60.76MShares678.21052wk High9.12P/B38.83BFloat Cap349.86052wk Low--Dividend TTM60.73MShs Float678.210Historical High--Div YieldTTM2.74%Amplitude17.330Historical Low638.293Avg Price1Lot Size
About argenx SE Company
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Company Profile
SymbolARGX
Company Nameargenx SE
Listing DateMay 18, 2017
Issue Price17.00
Founded2008
CEOMr. Tim Van Hauwermeiren, M. Sc.
MarketNASDAQ
Employees1148
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLaarderhoogtweg 25
CityAmsterdam
ProvinceNoord-Holland
CountryNetherlands (the)
Zip Code1101 EB
Phone31-76-303-04-88
Websitehttp://www.argen-x.com
Company Executives
- Name
- Position
- Salary
- Tim Van Hauwermeiren, M. Sc.
- Executive Director and Chief Executive Officer
- 17.45M
- Karl Gubitz
- Chief Financial Officer
- 4.76M
- Dr. Peter Ulrichts
- Chief Scientific Officer
- --
- Karen Massey
- Chief Operating Officer
- 7.32M
- Dr. Luc Truyen, M.D.,PhD
- Chief Medical Officer
- --
- Arjen Lemmen
- Vice President, Corporate Development and Strategy
- --
- Peter K.M. Verhaeghe
- Non-Executive Chairman of the Board
- 660.33K
- Camilla Sylvest
- Independent Director
- 365.24K
- Steven E. Krognes
- Independent Director
- 635.65K
- Anthony A. Rosenberg
- Independent Director
- 476.82K
- Dr. Pamela M. Klein, M.D.
- Independent Director
- 471.41K
- Dr. Ana Cespedes, PhD
- Independent Director
- 261.39K
- James M. Daly
- Independent Director
- 482.23K
- Dr. J. Donald deBethizy, PhD
- Independent Director
- 482.23K
- Malini Moorthy
- General Counsel
- --
- Andria Wilk
- Global Head, Quality
- --
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?